Who is sponsoring NCT05855031?

NCT05855031 is sponsored by Zealand University Hospital.

What drugs are being tested in NCT05855031?

Interventions in NCT05855031: Transient Elastography.

What condition does NCT05855031 study?

NCT05855031 studies Alcoholic Liver Disease, Alcohol Use Disorder, Alcohol Abuse, Alcoholism, Fibrosis, Liver, Alcohol-Related Disorders.

Is NCT05855031 still recruiting?

NCT05855031 is currently recruiting now. Last updated 17 May 2023.

Last reviewed 2023-05-17 · How we verify

NCT05855031

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Liver Care Trial

Recruiting now NA Last updated 17 May 2023

What this trial tests

NA trial testing Transient Elastography in Alcoholic Liver Disease in 408 participants. Currently enrolling.

Timeline

8 May 2023

Primary endpoint
1 November 2026

1 May 2027

Quick facts

Lead sponsor	Zealand University Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	screening
Enrollment	408
Start date	8 May 2023
Primary completion	1 November 2026
Estimated completion	1 May 2027
Sites	2 locations across Denmark

Drugs / interventions tested

Transient Elastography

Conditions studied

Alcoholic Liver Disease — all drugs for Alcoholic Liver Disease →
Alcohol Use Disorder — all drugs for Alcohol Use Disorder →
Alcohol Abuse — all drugs for Alcohol Abuse →
Alcoholism — all drugs for Alcoholism →

Sponsor

Zealand University Hospital

Who can join

Adults 18 to 110, any sex, with Alcoholic Liver Disease or Alcohol Use Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate the efficacy of screening for liver disease with liver stiffness measurement on abstinence or light consumption after 6 months in individuals who are receiving treatment for alcohol use disorder and without a history of liver disease. The investigators will conduct a randomized controlled trial with concealed allocation comparing A) an invitation to a liver stiffness measurement, blood sampling and leaflet on alcohol-related disease (intervention) with B) an invitation to blood sampling (control). The primary outcome is 'abstinence or light consumption' (≤ 10 units/week) throughout the last months, and assessed 6 months after randomization.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The Liver Care Trial: screening for liver disease in individuals attending treatment for alcohol use disorder-study protocol for a randomized controlled study.
Dahlin P, Jepsen P, Molzen L, Madsen LG, et al · · 2025 · PMID 41152905 · DOI 10.1186/s13063-025-09151-8
The Liver Care Trial: Screening for liver disease in individuals attending treatment for alcohol use disorder - study protocol for a randomized controlled study
Dahlin P, Jepsen P, Molzen L, Madsen LG, et al · · 2024 · DOI 10.21203/rs.3.rs-4609877/v1

Verify or expand the search:

Other trials of Transient Elastography

Trials testing the same drug.

NCT06867419 — Metabolic Features Effects on FAST Score in MASLD Patients · recruiting
NCT04595474 — Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes · active not recruiting

Other recruiting trials for Alcoholic Liver Disease

Currently open trials in the same condition.

NCT06307964 — Intra-Hepatic Microbiota in Alcoholic Hepatitis · recruiting
NCT05895890 — French National MICMAF Cohort · recruiting
NCT05007470 — Alcoholic Liver Disease and the Gut Microbiome · NA · active not recruiting
NCT04858412 — Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19 · NA · recruiting
NCT04666402 — Integrated Diagnostics for Early Diagnosis of Liver Disease · recruiting

Other Zealand University Hospital trials

Trials by the same sponsor.

NCT07373561 — Post-Intensive Care Syndrome and Associated Symptom Burden Among Danish ICU Survivors · not yet recruiting
NCT07386080 — Carbergoline for Antipsychotic Induced Hyperprolactinemia. · Phase 4 · not yet recruiting
NCT07482150 — The Connect Trial: Connecting Hospital Patients to Alcohol Care · NA · not yet recruiting
NCT07460999 — Singing Training vs Usual Care 6-18 Months After Surgical Resection for Non-small Cell Lung Cancer (NSCLC) · NA · recruiting
NCT07365527 — Sonoporation and Tumor Microenvironment Response in Colorectal Liver Metastases · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05855031 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zealand University Hospital
Last refreshed: 17 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05855031.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing